Related Experiment Video
Updated: Jun 8, 2025
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
3.5K
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance
Larisa H Cavallari1, J Kevin Hicks2, Jai N Patel3,4
1Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville.
Pharmacogenetics and Genomics
|November 1, 2024
Summary
Pharmacogenetics can personalize drug therapy, but its clinical use is limited. This global network aims to share data on implementing genotype-guided treatments to improve patient outcomes.
Area of Science:
- Pharmacogenomics and Precision Medicine
- Clinical Implementation Science
Background:
- Pharmacogenetics offers personalized drug selection and dosing based on individual genotypes.
- Despite evidence, pharmacogenetic testing is not widely used in clinical practice due to implementation challenges.
- Limited guidance exists for integrating genetic testing into clinical workflows and assessing outcomes.
Purpose of the Study:
- To establish a global network for sharing data on pharmacogenetic implementation strategies.
- To address barriers hindering the widespread adoption of genotype-guided drug therapy.
- To advance the clinical implementation of pharmacogenetics through collaborative research and data dissemination.
Main Methods:
- Engaging global institutions actively implementing or planning pharmacogenetic testing.
- Collecting and disseminating data on implementation strategies, metrics, and health outcomes.
- Facilitating collaborative opportunities for advancing pharmacogenetic implementation.
Main Results:
- The Pharmacogenomics Global Research Network Implementation Working Group has been formed.
- Initial projects and implementation priorities across participating sites are being defined.
- Focus on disseminating data to overcome barriers to clinical pharmacogenetic testing.
Conclusions:
- Collaborative efforts are crucial for overcoming barriers to pharmacogenetic implementation.
- Sharing implementation data will accelerate the integration of genotype-guided therapy into routine care.
- This network aims to improve patient outcomes through wider pharmacogenetic adoption.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
01:12Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
01:27Nonlinear Pharmacokinetics: Role of Transporters
35
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
35
02:02Genomics
36.0K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.0K